(Q46025676)

18 December 2017

title

Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. (English)

1 reference

18 December 2017

0 references

8

Michael Forsting

1 reference

18 December 2017

Andreas Bockisch

9

object named as

Andreas Bockisch

1 reference

18 December 2017

Gerald Antoch

10

object named as

Gerald Antoch

1 reference

18 December 2017

author name string

Till A Heusner

1

1 reference

18 December 2017

Sherko Kuemmel

2

1 reference

18 December 2017

Steffen Hahn

3

1 reference

18 December 2017

Angela Koeninger

4

1 reference

18 December 2017

Friedrich Otterbach

5

1 reference

18 December 2017

Monia E Hamami

6

1 reference

18 December 2017

Klaus R Kimmig

7

1 reference

18 December 2017

Alexander Stahl

11

1 reference

18 December 2017

publication date

5 May 2009

1 reference

18 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

18 December 2017

volume

36

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

1543-1550

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-009-1145-6

exact match

0 references

cites work

ABC of breast diseases. Prognostic factors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-009-1145-6

Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-009-1145-6

Treatment of the axilla in patients with screen-detected breast cancer

21 January 2018

1 reference

12 December 2020

Lymphatic Mapping and Sentinel Lymph Node Biopsy

1 reference

12 December 2020

Fluorodeoxyglucose-PET in the management of breast cancer

1 reference

12 December 2020

PET imaging in gynecologic malignancies

1 reference

12 December 2020

Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer

1 reference

12 December 2020

Evolving role of positron emission tomography in breast cancer imaging

1 reference

12 December 2020

Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients

1 reference

12 December 2020

A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases

1 reference

12 December 2020

The benefits and limitations of sentinel lymph node biopsy

1 reference

12 December 2020

Recent developments in PET detector technology

1 reference

12 December 2020

A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance

1 reference

12 December 2020

Axillary nodal status in women with screen-detected breast cancer

1 reference

12 December 2020

Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection

1 reference

12 December 2020

[Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing]

1 reference

12 December 2020

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

12 December 2020

Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors.

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

Methodological questions in sentinel lymph node analysis in breast cancer patients.

1 reference

12 December 2020

PET/CT: form and function

1 reference

12 December 2020

Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma

1 reference

12 December 2020

Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group

1 reference

12 December 2020

CT-pathologic correlation of axillary lymph nodes in breast carcinoma

1 reference

12 December 2020

Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update

1 reference

12 December 2020

Frequency and predictors of axillary lymph node metastases in invasive breast cancer

1 reference

12 December 2020

Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation

1 reference

12 December 2020

Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.

1 reference

12 December 2020

Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review

1 reference

12 December 2020

The Sentinel Node for Staging Breast Cancer: Current Review

1 reference

12 December 2020

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

12 December 2020

Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT.

1 reference

12 December 2020

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

1 reference

12 December 2020

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

1 reference

12 December 2020

Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?

1 reference

12 December 2020

Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity

1 reference

12 December 2020

Breast cancer staging in a single session: whole-body PET/CT mammography

1 reference

12 December 2020

The value of FDG positron emission tomography in the management of patients with breast cancer

1 reference

12 December 2020

Is there a role for positron emission tomography in breast cancer staging?

1 reference

12 December 2020

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer

1 reference

12 December 2020

10.1007/S00259-009-1145-6

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017